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Comparison of performance of self-expanding and
balloon-expandable transcatheter aortic valves
Hoda Hatoum, PhD,a,b Milad Samaee, PhD,c Janarthanan Sathananthan, MBChB, MPH,d
Stephanie Sellers, MSc, PhD,d Maximilian Kuetting, PhD,e Scott M. Lilly, MD, PhD,f
Abdul R. Ihdayhid, MBBS, PhD,g Philipp Blanke, MD,h Jonathon Leipsic, MD,h Vinod H. Thourani, MD,i
and Lakshmi Prasad Dasi, PhDc
ABSTRACT

Allegra

Objective: To evaluate the ﬂow dynamics of self-expanding and balloon-expandable
transcatheter aortic valves pertaining to turbulence and pressure recovery. Transcatheter aortic valves are characterized by different designs that have different
valve performance and outcomes.
Methods: Assessment of transcatheter aortic valves was performed using selfexpanding devices (26-mm Evolut [Medtronic], 23-mm Allegra [New Valve Technologies], and small Acurate neo [Boston Scientiﬁc]) and a balloon-expandable device
(23-mm Sapien 3 [Edwards Lifesciences]). Particle image velocimetry assessed the
ﬂow downstream. A Millar catheter was used for pressure recovery calculation. Velocity, Reynolds shear stresses, viscous shear stress, and pressure gradients were
calculated.
Results: The maximal velocity at peak systole obtained with the Evolut R, Sapien 3,
Acurate neo, and Allegra was 2.12  0.19 m/sec, 2.41  0.06 m/sec, 2.99  0.10 m/
sec, and 2.45  0.08 m/sec, respectively (P<.001). Leaﬂet oscillations with the ﬂow
were clear with the Evolut R and Acurate neo. The Allegra shows the minimal range
of Reynolds shear stress magnitudes (up to 320 Pa), and Sapien 3 the maximal (up to
650 Pa). The Evolut had the smallest viscous shear stress magnitude range (up to
3.5 Pa), and the Sapien 3 the largest (up to 6.2 Pa). The largest pressure drop at the
vena contracta occurred with the Acurate neo transcatheter aortic valve with a
pressure gradient of 13.96  1.35 mm Hg. In the recovery zone, the smallest pressure
gradient was obtained with the Allegra (3.32  0.94 mm Hg).
Conclusions: Flow dynamics downstream of different transcatheter aortic valves
vary signiﬁcantly depending on the valve type, despite not having a general trend
depending on whether or not valves are self-expanding or balloon-expandable.
Deployment design did not have an inﬂuence on ﬂow dynamics. (JTCVS Open
2022;10:128-39)

From the aDepartment of Biomedical Engineering, and bHealth Research Institute,
Center of Biocomputing and Digital Health and Institute of Computing and Cybernetics, Michigan Technological University, Houghton, Mich; cBiomedical Engineering Department, Georgia Institute of Technology, Atlanta, Ga; dCenter for
Cardiovascular Innovation, Cardiovascular Translational Laboratory, and hDepartment of Radiology, St Paul’s Hospital, University of British Columbia, Vancouver,
British Columbia, Canada; eNew Valve Technology, Hechingen, Germany; fDivision of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio; gFiona Stanley Hospital, Harry Perkins Institute of Medical
Research, Perth, Western Australia, Australia; and iDepartment of Cardiovascular
Surgery, Marcus Valve Center, Piedmont Heart Institute, Atlanta, Ga.
Drs Hatoum and Samaee contributed equally to this article as first authors.
Received for publication Nov 2, 2021; revisions received March 20, 2022; accepted
for publication April 12, 2022; available ahead of print May 16, 2022.

128

JTCVS Open c June 2022

Acurate Neo

Evolut

Pressure Gradient at VC [mmHg]

Pressure Gradient at X = 120mm [mmHg]

16

16

14

14

12

12

10

10

8

8

6

Pressure Gradient in the
recovery zone (Cath)

6

4
2

SAPIEN 3

4
Pressure Gradient at the vena
contracta (VC; Echo)

2

0

0
23mm
SAPIEN 3

26mm
Evolut R

S Acurate
Neo

23mm
Allegra

23mm
SAPIEN 3

26mm
Evolut R

S Acurate
Neo

23mm
Allegra

Comparison of self- and balloon-expandable TAV
performance.

CENTRAL MESSAGE

Flow dynamics downstream of
different TAVs vary signiﬁcantly
depending on valve type and size,
despite not having a general
trend depending on whether
valves are self-expanding or
balloon expandable.
PERSPECTIVE
TAVs are characterized by different designs (eg
self-expanding vs balloon-expandable) that dictate
different valve performance and outcomes. This
study aims to evaluate the ﬂow dynamics downstream of self-expanding and balloon TAVs pertaining to turbulence and pressure recovery. More
studies are needed to correlate hemodynamic
data with those observed in vivo.
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Abbreviations and Acronyms
PDF ¼ probability density function
PG ¼ pressure gradient
RSS ¼ Reynolds shear stress
TAV ¼ transcatheter aortic valve
VSS ¼ viscous shear stress

Video clip is available online.

Current commercially available transcatheter aortic valves
(TAV) are either self- or balloon-expandable. During the
past 2 decades, tremendous improvements in TAV designs
and materials took place to optimize valve performance
and maximize its benefits.1 Metals were replaced (stainless steel vs cobalt chromium) to ensure stronger and
more efficient anchoring, skirts were added and later
modified to limit regurgitation, and valve profiles were
altered to allow minimal interference with the downstream
flow. Despite these improvements, the interaction of each
TAV with the flow in the aortic root is associated with
nonphysiological flow properties compared with flow in
a native annuli.
Clinical, in vitro, and in silico studies have shown that
TAV performance varies with valve type (self-expanding
vs balloon-expandable),2-5 the unique design of each
valve within the same type group,6-8 the deployment
(axial and commissural),9-11 and the surrounding patientspecific anatomy.12-14 It is important to evaluate the flow
downstream of the aortic valve because it instructs
directly on the performance parameters and ultimately
durability (after sufficient follow-up). The turbulence of
the flow downstream of the TAV informs on the pressure
drop across the valve and explains some of the reasons
behind differences in pressure recovery among different
valves, as identified by different measurement modalities
such as echocardiography and catheterization.15 The turbulence of the flow downstream of the TAValso informs on the
forces that the platelets and red blood cells undergo, in the
context of general blood damage such as platelet activation,
thrombus formation, and hemolysis.2,16
In this study, we aim to characterize the differences in the
resulting flow dynamics and pressure recovery downstream
of multiple self-expanding and balloon-expandable TAVs.
METHODS
The hemodynamic assessment of a 26-mm Evolut (Medtronic), a 23mm Sapien 3 (Edwards Lifesciences), a small Acurate neo (Boston Scientific) and a 23-mm Allegra (New Valve Technologies) transcatheter heart
valve was performed in a left heart simulator under pulsatile physiological
conditions. These sizes are equivalent in that they treat similar-sized annuli
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(20-23 mm). For the study, the TAVs were implanted into a rigid test chamber described in previous publications.2,3,9,17 The aortic pressures ranged
from 80 to 120 mm Hg, the peak aortic pressure was set at 24 L/min,
and the heart rate at 60 beats per minute. The fluid used in the experiments
was a mixture of water-glycerin (60/40 by volume) with properties similar
to those of blood (density of 1060 kg/m3 and a kinematic viscosity of
3.5 cSt). The valves were placed in the same annulus of the same aortic
root as described in previous studies.2 Flow data were acquired using ultrasonic flow probes (HXL; Transonic Inc), and pressures at all the measurement locations were measured with a Millar catheter (ADInstruments Inc).
The Millar catheter was inserted along the centerline of the aortic valve
chamber. Recordings of the pressure at every axial location along the
ascending aorta with intervals of 5 mm downstream of the valves and
1 mm inside the valves. Position 0 mm corresponds to the most upstream
measurement (ventricular), and position 120 mm corresponds to the last
measurement point in the measurement region of the chamber. Fifty
consecutive cardiac cycles of aortic pressure, ventricular pressure, and
flow rate data were recorded at a sampling rate of 100 Hz at every measurement location. The mean transvalvular pressure gradient (PG) is defined as
the average of positive pressure difference between the ventricular and
aortic pressure curves during forward flow. The peak PG was obtained
from the instantaneous pressure waveforms. High-speed recording enface of the valve opening, and closing was performed at a frame rate of
1000 Hz.
Particle image velocimetry experiments were performed to assess the
flow downstream of each TAV. The flow was seeded with fluorescent
poly (methyl methacrylate)-rhodamine B particles with average diameter
of 10 mm. A laser sheet created by pulsed neodymium-doped yttrium
lithium fluoride single-cavity diode pumped solid-state laser coupled
with external spherical and cylindrical lenses shone on the region of interest
while acquiring high-speed images of the fluorescent particles within the
downstream region. Time series recordings were acquired at a temporal
resolution of 500 Hz. Phase-locked recordings were acquired to calculate
the resulting flow statistical parameters (Reynolds shear stress [RSS])
over 250 images. The RSS, an established metric to evaluate turbulence
and any associated blood damage potential, is a statistical quantity that is
used to describe a turbulent flow field.18,19 The principal RSS is calculated
as per Equation 1.
sﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
u0 u0 v0 v0 2
(Equation 1)
RSS ¼ r
þðu0 v0 Þ2
2
Where r is the blood density and u0 and v0 are the instantaneous velocity
fluctuations in the x and y directions, respectively.
In addition, viscous shear stress (VSS) was also computed as per Equation 2 and probability density functions (PDF) were calculated and plotted.


du dv
þ
(Equation 2)
t¼m
dy dx
Where t is in Pa and m is the dynamic viscosity in Ns/m2.

Statistics

The results are presented as mean  SD. Statistical analysis was performed using JMP Pro version 15.2.0 (SAS Institute Inc). All data were
distributed normally, and therefore, t test for paired comparison between
the vena contracta and recovery zone for each valve was performed
along with Tukey test for unpaired comparison for vena contracta and
recovery zone gradients of all valves. The instantaneous VSS over the
cardiac cycle are plotted as PDFs. The PDF displays all the values
(all the range) of a certain parameter distributed over a certain region
of interest and gives the relative or differential likelihood (frequency)
of any parameter. The area under the probability density function curve
is always equal to 1 and therefore can also be considered as a normalized histogram.20
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RESULTS
Downstream Flow Field
Figure 1 shows the averaged flow velocity downstream of
each of the TAVs at acceleration, peak systole, and deceleration phases. The dark streaks of red and blue vorticity contours represent the shear layers corresponding to the jet
boundaries and the distance between them represents the
width of the jet. As the flow starts accelerating, reaching
the tip of the fully open valve leaflets, it separates from
the leaflet tip and travels as a free shear layer that is a region
of concentrated vorticity, an indicator of flow rotation.
Because the resulting shear layers and jet stability are

Z (s–1)
–500 –250

0

Acceleration

consequences of the interaction between flow and leaflets,
it is important to visualize the opening of the valves.
Videos 1 through 4 show the gradual opening of each of
the valves (Evolut R, Sapien 3, Acurate neo, and Allegra,
respectively). Leaflet flutters are clear with the Evolut R
and Acurate neo; however, less noticeable with the Sapien
3 and the Allegra. From a different angle, Videos 5
through 8 show the flow as imaged in the experiments,
highlighting the leaflet motion during the cardiac cycle.
The maximal velocity at peak systole obtained with the
Evolut R, Sapien 3, Acurate neo, and Allegra was found
to be 2.12  0.19 m/sec, 2.41  0.06 m/sec,
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FIGURE 1. Phase-averaged velocity vectors and vorticity contours at different phases in the cardiac cycle. The dark streaks of red and blue vorticity contours represent the shear layers corresponding to the jet boundaries and the distance between them represents the width of the jet. The resulting shear layers
and jet stability are consequences of the interaction between flow and leaflets and thus, it gives important information on the visualization of the opening of
the valves and the resulting flow. The maximal velocity at peak systole obtained with the Evolut R (Medtronic), Sapien 3 (Edwards Lifesciences), Acurate
neo (Boston Scientific), and Allegra (New Valve Technologies) was found to be 2.12  0.19 m/sec, 2.41  0.06 m/sec, 2.99  0.10 m/sec, and 2.45  0.08 m/
sec, respectively (P <.001).
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VIDEO 1. En-face imaging of Evolut R (Medtronic). Video available at:
https://www.jtcvs.org/article/S2666-2736(22)00168-1/fulltext.

2.99  0.10 m/sec, and 2.45  0.08 m/sec, respectively
(P<.001). Comparing between each valve, significant differences were found except between the Sapien 3 and the
Allegra (P ¼ .957).
Downstream Flow Turbulence
Figure 2 shows the principal RSS at different phases in
the cardiac cycle. The maximum RSS occurs during peak
systole where the flow is maximal. The dark blue patches
indicate an elevated RSS magnitude, and the more prevalent
elevated RSS magnitudes are, the more turbulent the flow is
considered to be. The fluctuations observed in the RSS contours follow in evolution and distribution in the flow field
those seen in Figure 1.

VIDEO 2. En-face imaging of Sapien 3 (Edwards Lifesciences). Video
available
at:
https://www.jtcvs.org/article/S2666-2736(22)00168-1/
fulltext.

Adult: Aortic Valve

VIDEO 3. En-face imaging of Acurate neo (Boston Scientific). Video
available
at:
https://www.jtcvs.org/article/S2666-2736(22)00168-1/
fulltext.

To quantify the RSS distribution more accurately,
Figure 3, A, shows the probability density functions of
RSS for each of the TAVs at peak systole. The Acurate
neo and the Evolut R present the largest distributions of
RSS in all 3 phases (ie, acceleration, peak systole, and
deceleration). The Allegra shows the minimal range of
RSS magnitudes (up to 320 Pa), followed by the Evolut
(up to 600 Pa) and then the Acurate neo and Sapien 3 (up
to 650 Pa). In the literature, it was reported that a limit of
100 Pa to evaluate potential blood damage could be considered appropriate.21 Any value that exceeds 100 Pa is considered elevated enough to be associated with blood damage

VIDEO 4. En-face imaging of Allegra (New Valve Technologies). Video
available
at:
https://www.jtcvs.org/article/S2666-2736(22)00168-1/
fulltext.
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VIDEO 5. Raw video showing the flow downstream of the Evolut R (Medtronic). Video available at: https://www.jtcvs.org/article/S2666-2736(22)
00168-1/fulltext.

VIDEO 7. Raw video showing the flow downstream of the Acurate neo
(Boston Scientific). Video available at: https://www.jtcvs.org/article/
S2666-2736(22)00168-1/fulltext.

potential. In Figure 3, A, the Sapien 3, Acurate neo, and Allegra show equal distribution of RSS <100 Pa. The Evolut
shows a higher prevalence within this limit. For RSS
exceeding 100 Pa, the Allegra still shows the lowest distribution. The Evolut and the Sapien 3 show equal and largest
distribution up until an RSS limit of 210 Pa. When
210<RSS<450 Pa, the Acurate neo shows the largest likelihoods of development of elevated RSS. When RSS
>450 Pa, the Evolut shows the highest likelihoods of
elevated RSS up until 600 Pa. The Acurate neo shows
more elevated likelihoods when RSS >600 Pa compared
with the Sapien 3 because both these valves show such
elevated magnitudes.
To evaluate the actual shear force per unit area experienced by blood elements, we calculated the instantaneous
VSS for each of the valve flow fields and we plotted the
probability density function of the VSS in Figure 3, B. All
the instantaneous VSS magnitudes obtained were lower
than 10 Pa, a threshold associated with potential blood damage.18 The Evolut was shown to have the smallest magnitude range (up to 3.5 Pa), followed by the Allegra (up to

4.8 Pa), followed by the Acurate neo (up to 5.5 Pa) and
then the Sapien 3 (up to 6.2 Pa).

VIDEO 6. Raw Video showing the flow downstream of the Sapien 3 (Edwards Lifesciences). Video available at: https://www.jtcvs.org/article/
S2666-2736(22)00168-1/fulltext.
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Pressure Recovery
The importance of accounting for pressure recovery is
that it permits identification of the true PG across the TAV
and accordingly a more accurate assessment of performance. Figure 4 shows the variations of PGs along selected
locations in the aortic root with the 4 different valves and
Figure 5 shows the variations of the corresponding standard
deviations. A box-and-whisker plot is provided for the
instantaneous measurements in Figure E1. The results are
plotted from the ventricular side upstream of each valve
to the downstream side up until the end of the aortic testing
chamber (at 120 mm). As the flow crosses the valve, the PG
decreases from the ventricular side to the aortic 1 until it
reaches a minimum at the vena contracta (where the jet is

VIDEO 8. Raw video showing the flow downstream of the Allegra (New
Valve Technologies). Video available at: https://www.jtcvs.org/article/
S2666-2736(22)00168-1/fulltext.
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FIGURE 2. Principal Reynolds shear stresses (RSS) at different phases in the cardiac cycle. The dark blue patches indicate an elevated RSS magnitude, and
the more prevalent elevated RSS magnitudes are, the more turbulent the flow is considered to be. Evolut R (Medtronic), Sapien 3 (Edwards Lifesciences),
Acurate neo (Boston Scientific), and Allegra (New Valve Technologies).

the narrowest and where maximum jet velocity occurs). After that, the recovery process starts through a gradual increase in PG along the various points. All the valves
follow this expected pattern of pressure changes along positions in the aortic root.
The largest pressure drop at the vena contracta occurs
with the Acurate neo TAV where the minimal pressure reaches 13.96  1.35 mm Hg. The PG with the Sapien 3, Evolut, and Allegra reach 10.54  0.51 mm Hg,
10.64  0.38 mm Hg, and 11.89  0.61 mm Hg, respectively. The 23-mm Sapien 3 showed the smallest PG at
the vena contracta. The location of the vena contracta varied
with each valve. The vena contracta of the Acurate neo was
the closest to the valve entrance, and that of the Allegra was
the furthest from the valve entrance. At 12 mm, in the recovery zone, the smallest PG was obtained with the Allegra
(3.32  0.94 mm Hg), followed by Sapien 3
(3.68  0.76 mm Hg), then the Evolut R

(4.77  0.87 mm Hg) and the largest PG was obtained
with the Acurate neo (5  1.21 mm Hg).
All differences in PGs were statistically significant
(P <.001) except for the Allegra and Sapien 3 at the vena
contracta (P ¼ .1399) and the Acurate neo and Sapien 3
in recovery zone (P ¼ .2105).
The largest pressure recovery (difference between PG at
the vena contracta and PG at 120 mm) was obtained with
Acurate neo (8.96 mm Hg), followed by Allegra
(7.79 mm Hg), then by Sapien 3 (6.86 mm Hg), and then
Evolut R (4.47 mm Hg). From Figure 5, the fluctuations
in the SDs are higher with the self-expanding valves
compared with the Sapien 3. All differences in pressure recovery were statistically significant (P <.001).
DISCUSSION
In this study, we evaluated the hemodynamics downstream of 4 TAVs with variable leaflet position, 3 of which
JTCVS Open c Volume 10, Number C
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FIGURE 3. Probability density function (PDF) of the (A) Reynolds shear stress (RSS) distribution and the (B) viscous shear stress (VSS) distribution downstream of the Evolut R (Medtronic), Sapien 3 (Edwards Lifesciences), Acurate neo (Boston Scientific), and Allegra (New Valve Technologies) transcatheter
aortic valves in semi-log scale. 0.1 KPa represents a potential blood damage threshold. The Acurate neo and the Evolut R present the largest distributions of
RSS in all 3 phases (acceleration, peak systole, and deceleration). The Allegra shows the minimal range of RSS magnitudes (up to 320 Pa), followed by the
Evolut R (up to 600 Pa) and then the Acurate neo and Sapien 3 (up to 650 Pa).

are self-expanding valves (26-mm Evolut R, S Acurate neo,
and 23-mm Allegra) and 1 balloon expandable valve (23mm Sapien 3). We report findings on flow turbulence and
its relationship to potential for thrombogenicity due to
flow turbulence, and on pressure recovery along with its
relationship to the assessment of overall valve performance.
The higher the RSS and the VSS, the more the flow is
considered turbulent. Turbulence is an essential and important factor to assess after heart valve implantation because it
can lead to blood damage such as platelet activation,
thrombus formation, and hemolysis. Several studies have
specified thresholds above which forces on the platelets
are the red blood cells are nonphysiological, leading therefore to adverse effects related to blood damage.18,22 Additionally, several clinical studies have pointed to the
occurrence of thrombus formation and hemolysis after
various generations of TAVs. These findings were dependent on the type of the valve implanted and how every
unique valve design influences the resulting flow. Therefore, it is important to assess how valve performance and
behavior (eg, gradients, turbulence, and flutter) influence
or correlate with clinical findings.23-26 The connection
between blood damage and valve durability has also been
a subject of research in the recent years.27,28 Thus, understanding how every valve influences the resulting flow is
important to relate the findings to future outcomes after
TAV replacement.
In this study, the RSS (or turbulence shear stresses) were
evaluated to compare the resulting turbulence obtained
among the 4 valves. RSS is a pseudoforce and is often
used to provide a statistical quantitative evaluation of the
134
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influence of turbulent fluctuations on the averaged velocity
field at a given position in space.18 The Allegra TAV showed
the smallest range of RSS, indicating lowest turbulence
levels compared with the other valves. This result was
also accompanied by a small leaflet flutter frequency
(Videos 4 and 8), which helped with the flow stabilization
and with the reduction of RSS.2 The Acurate neo and the
Evolut R showed elevated likelihoods of developing
elevated RSS that exceed 0.1 KPa, a threshold adopted for
blood damage initiation,21 compared with the other valves.
Both valves also showed elevated flutter frequency (Videos
1, 3, 5, and 7) influencing the elevated RSS obtained in this
study. The elevated leaflet flutter could be attributed to the
supra-annular design of the leaflets and the location of the
tip of the leaflet in the Evolut R and the Acurate neo, in
addition to the porcine pericardium material of the leaflets.
Although this was clearly observed with these 2 selfexpanding valves, the Allegra showed minimal flutter (comparable with the Sapien 3) despite having supra-annular
leaflet design. This may be due to the small stent spaces (diamonds) and the compact frame of the Allegra compared
with a more open stent design with both the Evolut R (larger
diamonds) and the Acurate neo (open frame). This may also
be due to tissue thickness and leaflet geometry that are most
probably the main determinants of a complete circular
opening and the degree of leaflet fluttering at the time of
peak flow, which will ultimately determine flow patterns,
turbulence, shear stresses, pressure drop, and pressure
recovery.
Pressure recovery is an important phenomenon that instructs on the performance of the implanted valve.29 As
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FIGURE 4. A, Variations of pressure gradients as a function of axial distance at selected location points during peak systole with the 23-mm Sapien 3
(Edwards Lifesciences), 26-mm Evolut R (Medtronic), S Acurate neo (Boston Scientific), and 23-mm Allegra (New Valve Technologies) transcatheter aortic
valves. The results are plotted from the ventricular side upstream of each valve to the downstream side up until the end of the aortic testing chamber (at
120 mm). As the flow crosses the valve, the pressure gradient decreases from the ventricular side to the aortic one until it reaches a minimum at the
vena contracta (VC) (where the jet is the narrowest and where maximum jet velocity occurs). After that, the recovery process starts through a gradual increase
in pressure gradient along the various points. B, Bar plot showing the pressure gradients at the VC and the recovery zone at x ¼ 120 mm. The dark lines on the
bar plots indicate the SDs. The largest pressure drop at the VC occurs with the Acurate neo transcatheter aortic valve where the minimal pressure reaches
13.96  1.35 mm Hg. The pressure gradient with the Sapien 3, Evolut, and Allegra reach 10.54  0.51 mm Hg, 10.64  0.38 mm Hg, and 11.89  0.61 mm
Hg, respectively. The 23-mm Sapien 3 showed the smallest pressure gradient at the VC. The location of the VC varied with each valve. The VC of the
Acurate neo was the closest to the valve entrance, and that of the Allegra was the furthest from the valve entrance. At 12 mm, in the recovery zone, the
smallest pressure gradient was obtained with the Allegra (3.32  0.94 mm Hg), followed by Sapien 3 (3.68  0.76 mm Hg), then the Evolut R
(4.77  0.87 mm Hg) and the largest pressure gradient was obtained with the Acurate neo (5  1.21 mm Hg). All differences in pressure gradients
were statistically significant (P <.001) except for the Allegra and Sapien 3 at the VC (P ¼ .1399) and the Acurate neo and Sapien 3 in the recovery
zone (P ¼ .2105).

the jet expands downstream, its velocity starts decreasing
and pressure is recovered depending on several factors
such as turbulence, velocity of blood at the vena contracta, and the geometry of the aorta.3,13,14,30 Several
clinical studies presented detailed comparative works

between echocardiogram-based gradients (at the vena
contracta) and catheterization-based gradients (in the recovery zone).31-35 Some of these studies highlighted that
balloon-expandable valves are characterized by higher
gradients at the vena contracta and more elevated
JTCVS Open c Volume 10, Number C
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FIGURE 5. Variations of pressure gradient standard deviations as a function of axial distance at selected location points during peak systole with the 23-mm
Sapien 3 (Edwards Lifesciences), 26-mm Evolut R (Medtronic), S Acurate neo (Boston Scientific), and 23-mm Allegra (New Valve Technologies) transcatheter aortic valves. The fluctuations in the standard deviations are higher with the self-expanding valves compared with the Sapien 3. This complements
the elevated turbulent stresses obtained in this study.

pressure recovery.3,35 Some of these studies were
inconclusive.34
In this study, the Allegra TAV was characterized by the
lowest PG in the recovery zone and one of the highestpressure recoveries among the 4 valves. The Allegra, as
previously mentioned, was characterized by the smallest
turbulence downstream of the valve. The Acurate neo
was characterized by elevated turbulence, the most
elevated PG at the vena contracta and the most elevated
PG at 120 mm. However, the pressure recovery obtained
from the vena contracta to the 120-mm recovery zone
was the highest. The turbulence downstream of the Evolut
R was among the highest observed in this study, and the PG
at the recovery zone was the second most elevated with the
pressure recovery being the smallest. The effect of turbulence on the downstream flow of the valve was also clear
with the large fluctuations in standard deviations of the
PGs at the different locations. This study shows that pressure recovery is valve-dependent, although it is hard to
generalize the dependence on the self-expanding versus
the balloon-expandable type. With various valve types
and designs, more experiments and more clinical outcomes are needed to assess the optimally performing valve
type.
Although differences in gradients and pressure recovery
among the four types of valves were demonstrated in this
study, these differences may not be clinically significant
in terms of hemodynamic performance. However, the opening and closing characteristics, the degree of fluttering and
turbulence downstream the aorta may exert relevant influence in durability and long-term outcomes.
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Limitations
In this study, we used an idealized solid aortic root model
that led to a perfect circular TAV replacement deployment,
an advantage that may not be accomplished in many patients due to the anatomical characteristics of the native
valve and root. The absence of patient-specific factors influence the flow patterns downstream of the valve and these
characteristics have not been fully characterized at present
in this study. However, we aimed at performing a highly
controlled study that isolates the effect of each transcatheter
heart valve independently from geometric or deploymentrelated considerations, similar to previous studies.9,36-40
Moreover, in this study, only the recommended axial
deployment41 was assessed. Additionally, we performed
the hemodynamic assessment of these valves under 1 physiological set of conditions. Whether or not these conclusions hold under different physiological scenarios is yet to
be determined with more studies. Finally, we tested one
type of valves for each experiment. Variability in valve
type is not anticipated because the manufacturability of
these commercial valves is already established. It is also
key to acknowledge that such ex vivo modeling does not
factor in the biological aspects of platelets activation which
come into play.

CONCLUSIONS
The hemodynamics downstream of 4 transcatheter aortic
valves, 3 of which are self-expanding valves (26-mm Evolut
R, S Acurate neo, and 23-mm Allegra) and 1 balloon
expandable valve (23-mm Sapien 3) were evaluated in
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Flow dynamics downstream of self-expanding and balloon expandable transcatheter aortic valves
(TAV) relating to turbulence and pressure recovery
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Flow dynamics downstream of different TAVs vary significantly depending on the valve type,
despite not having a general trend depending on whether valves are self-expanding or balloon expandable.
PDF: Probability Density Function; RSS: Reynolds Shear Stress; VSS: Viscous Shear Stress.
FIGURE 6. Flow dynamics downstream of self-expanding and balloon expandable transcatheter aortic valves (TAVs) relating to turbulence and pressure
recovery. Evolut R (Medtronic), Sapien 3 (Edwards Lifesciences), Acurate neo (Boston Scientific), and Allegra (New Valve Technologies). PDF, Probability
density function; RSS, Reynolds shear stress; VSS, viscous shear stress.

this study under pulsatile conditions in vitro. There was a
distinct trend of performance obtained with each valve independent of whether they are self-expanding or balloonexpandable, as summarized in Figure 6. The Allegra valve,
a self-expanding valve, and the Sapien 3 valve, a balloonexpandable valve, were characterized by the lowest leaflet
flutter and thus, the lowest turbulence downstream. These
results were supported by the lowest PG results along the
pressure recovery zone and minimal fluctuations as evidenced by the SDs of the PG downstream of the valve.
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FIGURE E1. Box-and-whisker plot showing the pressure gradient distribution for each valve case. The lower and upper borders of the box (Q1 and Q3)
represent the lower and upper quartiles (25th percentile and 75th percentile). The middle horizontal line (Q2) represents the middle value in the data set (50th
percentile). The lower and upper lines (Q0 and Q4, which are known as whiskers) represent variability outside the upper and lower quartiles (0th percentile
and 100th percentile, respectively) and show the minimum and maximum values of nonoutliers. Extra dots represent outliers, which differ significantly from
the rest of the dataset. Evolut R (Medtronic), Sapien 3 (Edwards Lifesciences), Acurate neo (Boston Scientific), and Allegra (New Valve Technologies). VC,
Vena contracta.
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